Buying guide
Apple Watch vs Garmin (Venu / Fenix / Forerunner) in 2026
Comparing 2 humanoid robots across availability, pricing, capabilities, and verified deployments. Current as of 2026.
| Attribute | No image on file | No image on file |
|---|---|---|
| Manufacturer | Apple | Garmin |
| Form factor | biometric | biometric |
| Maturity | commercial | commercial |
| Availability | shipping-nowshipping | shipping-nowshipping |
| Price | $399-$799 (actual sale price) | $449-$1,699 (actual sale price) |
| Capability claims |
|
|
| Brain | — | — |
| Verified deployments | 1Apple | 1Garmin |
| Privacy practices | 13cloud-upload, third-party-sharing, location-tracking, on-device-processing, training-data-use, data-sale, data-retention, biometric-storage, data-deletion-control, data-sale, data-deletion-control, data-retention, biometric-storage | 5location-tracking, third-party-sharing, data-retention, data-deletion-control, cloud-upload |
| Sources on file | 26 | 18 |
Editorial summaries
Apple Watch
The Apple Watch (current Series 11 and Ultra 3, September 2025; Series 9/10 and Ultra 2 supported) is a biometric-primary smartwatch and the canonical reference of the biometric cohort, with the broadest FDA-cleared portfolio: ECG and AFib/irregular-rhythm notifications (De Novo 2018), sleep-apnea notifications (2024), and hypertension notifications (2025), plus fall and crash detection and the Vitals app. Its sensors (optical PPG, electrical ECG, temperature, accelerometer/gyro, blood-oxygen) need no subscription for the FDA-cleared medical features. Pricing anchors at about $399 for the Series base (aluminum, GPS), with the Ultra around $799 and the SE around $249 (the SE lacks ECG). A within-entity verified-vs-claimed exemplar: blood-oxygen was disabled in the US in January 2024 over the Masimo ITC ruling and re-enabled in August 2025 via a paired-iPhone calculation redesign. DEPLOY holds the claims to the specific cleared indications: these are cleared features with defined scope, not a general cardiac or sleep diagnostic.
Garmin (Venu / Fenix / Forerunner)
Garmin (the Venu 3 as the biometric-primary anchor at about $449; the Fenix 8 and Forerunner 965 are more athletics-primary and pricier) is the lightest-cleared-portfolio entry in the biometric cohort. Its sensors (Elevate optical heart rate, Pulse Ox/SpO2, ECG on select models, skin temperature) drive Body Battery, Training Load and Training Readiness, advanced sleep and a sleep coach, all-day stress and HRV Status, and a Morning Report. The verified-vs-claimed distinction matters here: only the ECG is FDA-cleared (a 510(k) in 2023, on select models); Body Battery, recovery, and the broader readiness metrics are wellness-grade, and Pulse Ox is not FDA-cleared. Garmin is purchase-only (founded 1989); the optional Garmin Connect+ AI subscription ($6.99/month, March 2025) does not gate any existing features. DEPLOY cap-flags any reading of Garmin's wellness metrics as cleared diagnostics; only the ECG carries a clearance.
Machine-readable: this page as markdown.